🇺🇸 FDA
Patent

US 11123344

Bupropion as a modulator of drug activity

granted A61KA61K31/137A61K31/138

Quick answer

US patent 11123344 (Bupropion as a modulator of drug activity) held by AXSOME THERAPEUTICS, INC. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/137, A61K31/138, A61K31/4748, A61K31/485